Mutations in presenilins (PS) are the major cause of familial Alzheimer's disease (FAD) and have been associated with calcium (Ca 2+ ) signaling abnormalities. Here, we demonstrate that FAD mutant PS1 (M146L) and PS2 (N141I) interact with the inositol 1,4,5-trisphosphate receptor (InsP 3 R) Ca 2+ release channel and exert profound stimulatory effects on its gating activity in response to saturating and suboptimal levels of InsP 3 . These interactions result in exaggerated cellular Ca 2+ signaling in response to agonist stimulation as well as enhanced low-level Ca 2+ signaling in unstimulated cells. Parallel studies in InsP 3 R-expressing and -deficient cells revealed that enhanced Ca 2+ release from the endoplasmic reticulum as a result of the specific interaction of PS1-M146L with the InsP 3 R stimulates amyloid beta processing, an important feature of AD pathology. These observations provide molecular insights into the ''Ca 2+ dysregulation'' hypothesis of AD pathogenesis and suggest novel targets for therapeutic intervention.
INTRODUCTION
Alzheimer's disease (AD) is a common dementia involving slowly developing and ultimately fatal neurodegeneration. Most AD is sporadic and usually develops at age >60, but $10% of AD is inherited as an autosomal-dominant trait (familial AD, FAD) and disease develops as early as the late 30 years of age. Mutations in amyloid precursor protein (APP) and presenilins (PS1, PS2) cause early onset FAD (Hutton and Hardy, 1997) . Hallmark features of AD include accumulations of extracellular b amyloid (Ab) plaques and intracellular neurofibrillary tangles with neuronal atrophy or loss (Hardy, 2006; Mattson, 2004) . The ''amyloid hypothesis'' of AD postulates that accumulation of oligomeric or fibrillar Ab, due to production of more amyloidogenic forms of Ab and defective processing and clearance, leads to pathological sequelae associated with the disease (Haass and Selkoe, 2007; Hardy and Selkoe, 2002) . This hypothesis has nevertheless been questioned (De Strooper, 2007; Hardy and Selkoe, 2002; Shen and Kelleher, 2007) , and others have also been proposed to describe pathological origins of the disease (reviewed in Blennow et al., 2006; Mattson, 2004) . Accumulating evidence suggests that sustained disruption of intracellular Ca 2+ signaling may play an early proximal, and perhaps central, role in AD pathogenesis (Gandy et al., 2006; LaFerla, 2002; Mattson and Chan, 2003; Smith et al., 2005a; Stutzmann, 2005) . Ca 2+ is involved in many facets of neuronal physiology, including activity, growth and differentiation, synaptic plasticity, and learning and memory, as well as pathophysiology, including necrosis, apoptosis, and degeneration (Berridge et al., 2000) . Before identification of PS, Ito (Ito et al., 1994) discovered that fibroblast lines derived from AD patients, later shown to harbor the A246Q mutation in PS1, without exception, generated exaggerated intracellular Ca 2+ concentration ([Ca 2+ ] i ) responses to submaximal concentrations of two G protein-coupled receptor (GPCR) agonists that activate phospholipase C (PLC). Activation of GPCR, including bradykinin, 5HT 2A and metabotropic glutamate receptors, stimulates PLC activity that produces inositol 1,4,5-trisphosphate (InsP 3 ), which binds to its receptor (InsP 3 R), an endoplasmic reticulum (ER)-localized Ca 2+ channel, resulting in release of Ca 2+ from the ER and elevation of [Ca 2+ ] i (Foskett et al., 2007) . Enhanced Ca 2+ release could not be attributed to altered amounts of Ca 2+ in the ER or number of agonist receptors or to plasma membrane influx pathways (Ito et al., 1994) . It was suggested that alteration of InsP 3 R-mediated Ca 2+ release was a fundamental defect in AD, although the molecular mechanisms were undefined. Subsequently, it was demonstrated that enhanced InsP 3 -mediated Ca 2+ signaling was a highly predictive diagnostic feature of AD-derived peripheral cells (Hirashima et al., 1996) . Many subsequent studies have confirmed that mutant PS expression is associated with exaggerated ER Ca 2+ release in several cellular and animal model systems including cells from FAD patients (Etcheberrigaray et al., 1998; Hirashima et al., 1996; Ito et al., 1994) , neuronal and nonneuronal cells engineered to express recombinant mutant PS proteins (CedazoMinguez et al., 2002; Guo et al., 1996; Johnston et al., 2006; Leissring et al., 1999a Leissring et al., , 1999b Leissring et al., , 2001 Smith et al., 2002) and cells from mutant PS transgenic animals (Leissring et al., 2000) , including brain neurons (Barrow et al., 2000; Mattson et al., 2000; Schneider et al., 2001; Stutzmann et al., 2004 Stutzmann et al., , 2006 long before the appearance of plaques and tangles (Stutzmann et al., 2004) . A ''Ca 2+ overload'' hypothesis has been widely invoked to account for exaggerated Ca 2+ release in mutant PS-expressing cells (discussed in Stutzmann, 2005) , but increased ER Ca 2+ stores have not been consistently observed (Giacomello et al., 2005; Ito et al., 1994; Lessard et al., 2005; Zatti et al., 2004 Zatti et al., , 2006 nor is there a consensus regarding possible molecular mechanisms involved (Gandy et al., 2006; LaFerla, 2002; Smith et al., 2005a; Stutzmann, 2005) . Here, we have discovered a mechanism that can account for intrinsic altered Ca 2+ signaling in AD cells that involves a biochemical and functional interaction of WT and FAD mutant PS with the InsP 3 R Ca 2+ release channel.
The biochemical interactions of FAD mutant PS1 or PS2 with the InsP 3 R profoundly enhance the activity (gating) of the channel that results in and can account for exaggerated cellular Ca 2+ signaling. By use of InsP 3 R-deficient cells, we show that this enhancement is directly involved in mutant PS-mediated APP processing (Ab generation), an important feature of AD pathology (Mattson and Guo, 1997) .
RESULTS

Modulation of InsP 3 R Channel Activity by PS1 in Sf9 Cells
The effects of PS expression on InsP 3 R channel activity were examined in native ER membranes by single-channel patch-clamp electrophysiology of the outer membrane of isolated Sf9 cell nuclei (Ionescu et al., 2006) . Insect cells express a single InsP 3 R isoform, most closely related to the mammalian type 1 channel, the predominant brain isoform (Foskett et al., 2007) , that has permeation and gating properties and ligand regulation very similar to those of mammalian InsP 3 R channels (Ionescu et al., 2006) . In membrane patches from control nuclei, InsP 3 R channels exposed to optimal ligand conditions (10 mM InsP 3 , 1 mM Ca 2+ ) were consistently detected, and they gated with high open probability (P o = 0.76 ± 0.05, n = 10; Figure 1B and see Table S1 available online). Human wild-type PS1 (PS1-WT) and FAD mutant PS1 M146L (PS1-M146L) were expressed in Sf9 cells as fulllength holoproteins ( Figure S1 ) throughout the ER (not shown) and in the nuclear envelope ( Figure S2 ). In nuclei from either FAD mutant PS1-M146L-or PS1-WT-expressing cells, no novel ion channels were detected (n = 59; Figure 1A ). Nor were channel activities observed in the absence of InsP 3 (n = 10; Figure 1A ) or in the presence of InsP 3 together with its competitive inhibitor heparin (100 mg/ml; n = 7; not shown). InsP 3 R channels observed in the presence of saturating 10 mM InsP 3 in membrane patches Table S1 .
from PS1-WT-infected cells had P o similar to those from mockinfected or uninfected cells (p > 0.05; Figures 1B and 1D ). In contrast, P o was elevated (p < 0.05) in PS1-M146L-infected cells (P o = 0.86 ± 0.03; Figures 1B and 1D) , with many channels observed to be ''locked open'' for long periods (as in Figure 1B ), a gating behavior only extremely rarely observed in control channels (unpublished data). PS1-M146L enhanced InsP 3 R gating in saturating [InsP 3 ] by prolonging the channel open time ( Figure 1E ). Interestingly, PS1-WT also enhanced the mean open time, although to a lesser extent than mutant PS1 (Figure 1E) , and it also enhanced the mean closed time ( Figure 1F ). With [InsP 3 ] lowered to 33 nM, InsP 3 R channel P o in patches from control nuclei was reduced to 0.27 ± 0.01, reflecting the [InsP 3 ] dependence of gating (Ionescu et al., 2006) . Strikingly, P o was elevated by nearly 3-fold in patches from nuclei isolated from the FAD mutant PS1-expressing cells (P o = 0.75 ± 0.06), to a level that was comparable to that observed in saturating [InsP 3 ] ( Figures 1C and 1D ). Enhanced P o was caused by a marked destabilization of the channel closed state (enhanced opening rate) as well as prolongation of the open time ( Figures 1E and 1F ). In contrast, PS1-WT was without effect on P o ( Figure 1D ); although it appeared to influence channel gating, reflected as a small increase of the channel mean closed time ( Figure 1F ).
Biochemical Interaction of PS1 with InsP 3 R
These results demonstrate a gain-of-function effect of mutant PS1 on InsP 3 R channel activity observed at the single-channel level. Because the effects of FAD PS1 expression were observed in isolated nuclei, we speculated that this functional effect was caused by an association of PS with the InsP 3 R in the ER membrane patches. PS1-WT and PS1-M146L immunoprecipitates from Sf9 cells that had been co-infected with rat types 1 or 3 InsP 3 R contained both InsP 3 R channel isoforms (Figure 2A) . Similarly, PS1 immunoprecipitates from mouse whole brain lysates contained the type 1 InsP 3 R ( Figure 2C ). These results demonstrate a biochemical interaction between InsP 3 R and both WT and mutant PS1.
Modulation of InsP 3 R Channel Activity by PS1 in DT40 Cells Similar studies were undertaken in chicken DT40 cells, using analogous protocols, but with polyclonal lines engineered to stably express either WT or mutant PS1 proteins ( Figure S3) . A DT40 line with all three InsP 3 R isoforms genetically deleted (InsP 3 R-KO DT40) constitutes the only InsP 3 R null cell line available (Sugawara et al., 1997) . We reasoned that if PS1 similarly affected gating of InsP 3 R channels in native InsP 3 R-expressing DT40 cells, the generality of this as a molecular mechanism associated with FAD mutant PS1 could be established, and furthermore that use of InsP 3 R-KO DT40 cells would be valuable for investigating the physiological relevance of the PS-InsP 3 R interaction. As in the Sf9 cell recordings, no novel ion channel activities were observed in nuclei from the wild-type or mutant PS1-expressing native DT40 cells (not shown). Importantly, highly similar effects of PS expression on InsP 3 R channel behavior were observed as in the Sf9 cells (Figure 3 ; Table S2 ). Thus, in saturating [InsP 3 ], PS1-WT was without effect (P o = 0.53 ± 0.05 in control versus 0.57 ± 0.07 in PS1-WT transfected cells), whereas PS1-M146L expression increased channel activity (P o = 0.83 ± 0.04; p < 0.01; Figures 3A and 3C ) by locking the channel open for long periods ( Figure 3D ). In suboptimal [InsP 3 ] (100 nM), mutant PS1 stimulated channel activity by 4-fold (P o = 0.63 ± 0.07 versus 0.16 ± 0.02 for control cells; Figures 3B and 3C ) to levels similar to those observed for control channels in saturating [InsP 3 ]. Also as in Sf9 cells, PS1-WT was without effect on P o , although it influenced channel gating, as evidenced by small effects on both mean open and closed times ( Figures 3D and 3E) . The similar behaviors of InsP 3 R gating from different species in different cell systems in response to expression of FAD mutant and WT PS1 strongly suggests that this is a fundamental channel regulatory mechanism.
Modulation of InsP 3 R Channel Activity by PS2 Altered [Ca 2+ ] i signaling has been observed in cells expressing either FAD mutant PS1 or PS2 (Gandy et al., 2006; LaFerla, 2002; Smith et al., 2005a; Stutzmann, 2005) . Like PS1, wildtype PS2 (PS2-WT) and FAD mutant PS2 N141I (PS2-N141I) also localized to the nuclear envelope ( Figure S2 ) and interacted biochemically with the InsP 3 R (Figures 2B and 2C ). With 10 mM InsP 3 in the pipette solution, InsP 3 R channels from PS2-WT-infected cells ( Figure S1 Table  S3 ). In contrast, P o was elevated (p < 0.05) in PS2-N141I expressing cells (P o = 0.81 ± 0.02; Figure 4C ). As observed for PS1-M146L, many channels observed in PS2-N141I nuclei were ''locked open'' (as in Figure 4A ). With subsaturating [InsP 3 ], P o in patches from PS2-N141I nuclei was elevated by nearly 3-fold compared with P o observed in nuclei from mock or PS2-WT-expressing cells ( Figure 4C ). Similar to the effect of PS1-M146L, elevated P o was caused primarily by marked enhancement of the opening rate and prolongation of the mean open time ( Figures 4D and 4E ). PS2-WT was without effect on channel P o ( Figures 4B and 4C ), but it influenced gating, reflected as increases in the mean closed and open times (Figures 4D and 4E) . These effects of WT and FAD mutant PS2 on InsP 3 R gating are highly similar to those observed for WT and mutant PS1, respectively, strongly suggesting that aberrant modulation of InsP 3 R channel gating is a general property of FAD mutant PS. Figure 5A ) due to InsP 3 -mediated Ca 2+ release from intracellular stores (Sugawara et al., 1997) . In PS1-WT-expressing cells, the magnitude and kinetics were similar to those observed in control cells. In contrast, exaggerated [Ca 2+ ] i responses were observed in PS1-M146L-expressing cells ( Figure 5A ), with the peak response over 1.5-fold higher than in control or PS1-WT-expressing cells ( Figure 5B ). Thus, the DT40 cell system recapitulates the exaggerated [Ca 2+ ] i responses observed in peripheral cells from FAD patients and neuronal and nonneuronal animal and model cells expressing FAD mutant PS. In response to a low anti-IgM concentration (0.05 mg/ml) expected to generate less InsP 3 , repetitive [Ca 2+ ] i oscillations were triggered in 52% ± 5% of control cells (Figures 5C and 5D) , due to periodic Ca 2+ release through the InsP 3 R (White et al., 2005 ) after a long lag period ( Figure 5F ) as [InsP 3 ] increased to levels sufficient for channel stimulation. In cells expressing PS1-M146L, the peak amplitude of the oscillations was similar to those observed in control and PS1-WT-expressing cells ( Figure S4 ), whereas both the oscillation frequency and number of responding cells were increased, and the latency between application of agonist and the first [Ca 2+ ] i response was decreased ( Figures 5C-5F ). Of note, the latency was nearly abolished in Table S2 . a significant subset ($30%) of cells expressing PS1-M146L (Figures 5C and 5F ). This response is highly reminiscent of that of control cells to saturating concentrations of BCR antibody ( Figure 5A ) and was never observed in control or PS1-WT-expressing cells. Figure 5H ). In contrast, a 4-fold higher percentage, $25%, of the PS1-M146L-expressing cells exhibited spontaneous [Ca 2+ ] i oscillations ( Figure 5H ). Furthermore, the oscillation frequency in these cells was also enhanced ( Figure 5I ). In a subset of the mutant PS1-expressing cells ($4%), spontaneous exaggerated [Ca 2+ ] i transients were observed that were never seen in control and PS1-WT-expressing cells ( Figure 5G ).
These results are congruent with those obtained in the singlechannel studies. In both sets of experiments, exaggerated responses to InsP 3 , particularly under conditions of low [InsP 3 ], were observed in the context of FAD mutant PS1 expression, with PS1-WT expression also having effects, but much less exaggerated. The congruence of two very different sets of data suggests that the observed exaggerated [Ca 2+ ] i responses are due to the observed exaggerated InsP 3 R single-channel responses. (LaFerla, 2002; Smith et al., 2005a; Stutzmann, 2005; Yoo et al., 2000) , but it has been suggested that they are caused by enhanced expression of release channels (Chan et al., 2000; Kasri et al., 2006; Schneider et al., 2001; Smith et al., 2005b; Stutzmann et al., 2006) or overfilling of ER Ca 2+ stores (Leissring et al., 2000; Leissring et al., 2001; Schneider et al., 2001; Tu et al., 2006) . We therefore examined whether either factor contributed to the exaggerated [Ca 2+ ] i responses observed here in DT40 cells. All three cell lines expressed approximately equal levels of the types 1 and 3 InsP 3 R ( Figure S3) . Thus, the exaggerated responses cannot be accounted for by altered InsP 3 R expression in our studies. ] i responses were due entirely to Ca 2+ derived from intracellular compartments.
Exaggerated
Ionomycin (5 mM) triggered a rapid release of Ca 2+ that was diminished in the PS1-M146L-but not PS1-WT-expressing cells ( Figure S5 ). Similarly, Ca 2+ released in response to thapsigargin (1 mM) was also significantly reduced in the mutant Table S3 .
Neuron
Presenilins Regulate InsP 3 R Channel Gating PS1-expressing cells and, to a lesser extent, in the PS1-WT-expressing cells ( Figure S5 (Figure 6 ). At steady state, the stores in the FAD PS1-expressing cells were loaded less fully than in control or PS1-WT-expressing cells ( Figure 6A ; p < 0.01), confirming that the Ca 2+ stores are not overloaded in the mutant PS1-expressing cells. In contrast, when loading was performed in the presence of the InsP 3 R inhibitor heparin, the steady-state level of ER Ca 2+ was similar in all the cell lines ( Figure 6B Figures 6C and 6D ). This enhanced Ca 2+ leak observed in the PS1-M146L cells was eliminated by addition of heparin ( Figures 6E and 6F ), suggesting that it was mediated by the InsP 3 R. To test this rigorously, we generated stable PS1-expressing DT40 cells with genetic disruption of all three InsP 3 R genes (Sugawara et al., 1997) . In the absence of InsP 3 R expression ( Figure S3 ), both anti-IgM-induced and spontaneous [Ca 2+ ] i signals were absent (not shown). Notably, the sizes of the intracellular Ca 2+ stores in the PS1-M146L-or PS1-WT-expressing cells were similar in the InsP 3 R-deficient cells ( Figure 6G ). Importantly, the enhanced PS1-M146L induced ER Ca 2+ leak rate was absent in the InsP 3 R-deficient cells ( Figure 6H ). These results demonstrate that exaggerated Ca 2+ signaling, reduced Ca 2+ store size, and enhanced ER Ca 2+ leak permeability are specific properties of PS1-M146L-expressing cells and, furthermore, that these features are completely dependent on the InsP 3 R. Together, these results strongly suggest that mutant PS1-M146L diminishes the size of the ER Ca 2+ store by a mechanism that involves its enhancement of InsP 3 R channel activity, a process that disrupts the normal Ca 2+ pump/leak balance in favor of enhanced leak mediated by ] expressed as Mag-Fura-2 ratio normalized to ratio at t = 0 before and then during filling upon addition of MgATP (1.5 mM) and subsequent emptying by addition of InsP 3 (10 mM) in control (blue) and PS1-WT (red) and PS1-M146L (green) Figure 7A ). The steady-state level of Ca 2+ accumulated in the ER lumen was not different between control cells and neurons expressing either WT or M146L-PS1 ( Figure 7B ). The Ca 2+ leak permeability measured upon addition of thapsigargin was somewhat higher in PS1-M146L expressing neurons than in those expressing PS1-WT (p < 0.05), although it was not different compared with control cells (Figure 7C ). In a separate set of experiments ( Figure 7D ), 33 nM InsP 3 failed to elicit Ca 2+ release in control or PS1-WT cells, whereas it simulated Ca 2+ release from the ER of PS1-M146L cells ( Figure 7E) , with an initial rate that was comparable to that achieved by addition of saturating (10 mM) InsP 3 to the control cells ( Figure 7F ). Thus, as in the nonneuronal cells examined, FAD mutant PS1 specifically sensitizes InsP 3 R-mediated Ca 2+ release in brain cortical neurons.
Neuron Presenilins Regulate InsP 3 R Channel Gating
Functional Consequences of InsP 3 R-PS1 Interaction-APP Processing Identification of a molecular mechanism that links FAD mutant PS to altered [Ca 2+ ] i signaling provides an opportunity for insights into relationships between pathological features of AD and altered [Ca 2+ ] i signaling. PS1 is the core subunit of the g-secretase that enzymatically cleaves APP into amyloid peptides, including Ab 40 and Ab 42 (Edbauer et al., 2003) . FAD PS mutations alter secretase function by either modifying its sequence specificity or absolute activity, such that the relative proportion or amount of Ab 42 produced is increased (Citron et al., 1997; Scheuner et al., 1996) . To determine the relevance of the functional interaction of PS1 and InsP 3 R for APP processing, we engineered DT40 cells to stably express APP harboring Swedish mutations (APP SWE ) that enhance production of Ab species (Scheuner et al., 1996) , together with either PS1-WT or PS1-M146L ( Figure 8A ). PS1-M146L specifically enhanced Ab 40 and Ab 42 by $2-and $3-fold, respectively, compared with control cells. This result is consistent with observations in other cell types (Citron et al., 1997) , validating again the use of this model system. Of note, the Ab 42 /Ab 40 ratio was enhanced in the FAD mutant PS1-expressing cells (Figure 8 ), as observed in AD patients. To determine the role of the InsP 3 R in PS1-dependent APP processing, APP and PS1-expxressing cells were generated in the InsP 3 R-KO background, and APP processing was similarly evaluated. Remarkably, the mutant PS1 enhancement of Ab secretion observed in the InsP 3 R-expressing cells was abolished. Furthermore, the absolute levels of Ab peptides detected were strongly reduced in all control and PS1-expressing InsP 3 R-KO lines ( Figure 8B ). These results indicate that altered APP processing by mutant PS1-M146L PS1 has a strong dependence on the InsP 3 R.
DISCUSSION
The underlying pathogenic mechanisms of Alzheimer's disease remain obscure. In this study, we considered that dysregulated [Ca 2+ ] i signaling is a proximal mechanism in AD. We used nonneuronal model cell systems because they provided unique advantages for deciphering the molecular mechanisms involved and confirmed the major results in primary brain neurons. Both the InsP 3 R (Foskett et al., 2007) as well as presenilins (Hebert et al., 2004) are widely distributed throughout all tissues investigated, with the highest levels of PS expression outside the brain (Hebert et al., 2004) , and similar Ca 2+ signaling abnormalities have been observed in several peripheral and neuronal cell types that express mutant PS (LaFerla, 2002; Smith et al., 2005a; Stutzmann, 2005 
Neuron
Presenilins Regulate InsP 3 R Channel Gating the gating of single InsP 3 R Ca 2+ release channels. We attempted to ensure equal levels of expression of InsP 3 R and the different PS proteins among the different groups of cells, but this could not be achieved perfectly. Nevertheless, because very similar results were obtained in two very distinct cell systems, Sf9 and DT40 cells, this was likely not a significant confounding variable. In both systems, mutant PS expression caused the InsP 3 R channel to gate as actively in low submaximal [InsP 3 ] as it normally does in saturating [InsP 3 ]. Elevated P o in low [InsP 3 ] by FAD mutant PS was caused primarily by a substantial increase of channel opening rate, the major mechanism whereby InsP 3 activates the channel (Foskett et al., 2007) , indicating that mutant PS enhances InsP 3 R gating by sensitizing it to low [InsP 3 ]. This mechanism is likely an allosteric one mediated by interaction of PS with the InsP 3 R that is preserved in isolated nuclei. Both membrane proteins localized to the nuclear envelope and mutant-as well as WT-PS coimmunoprecipitated to the same extent with mammalian InsP 3 R, suggesting that PS mutations do not strongly affect the biochemical interaction. Although WT PS1 or PS2 did not affect channel P o , small effects on InsP 3 R channel gating were nevertheless observed. It has been debated whether FAD PS mutations are gain or loss of function (Shen and Kelleher, 2007) . Here, we show an apparent gain in InsP 3 R function by FAD mutant PS expression. However, channel dwell time analyses suggest that WT PS1 and PS2 also influence InsP 3 R channel gating. It is possible therefore that the gain-of-function phenotype we observe is due to disruption by mutant PS of normal PS-WT regulation of InsP 3 R channel activity. Future studies of the InsP 3 R gating behaviors in PS-deficient cells will be informative in this regard.
FAD Mutant PS1-Mediated Enhanced InsP 3 R Gating Causes Exaggerated [Ca
2+
] i Signaling Analysis of our single-channel data suggests that mutant PS1 and PS2 stimulate InsP 3 R gating by sensitizing the channel to InsP 3 . One of the most consistent observations of the effects of FAD PS on Ca 2+ signaling is potentiation of InsP 3 -mediated Ca 2+ release (Smith et al., 2005a; Yoo et al., 2000) . Nevertheless, the molecular mechanisms have remained obscure. InsP 3 -mediated [Ca 2+ ] i signals in FAD patient fibroblasts were exaggerated in response to low agonist concentrations (Ito et al., 1994) , consistent with an enhanced sensitivity to InsP 3 in AD. The magnitude and rate of [Ca 2+ ] i rise in response to photo-release of InsP 3 were enhanced by FAD mutant PS in Xenopus oocytes (Leissring et al., 1999a (Leissring et al., , 1999b (Leissring et al., 2001) . In brain slices from PS1-M146V knockin mice, photo-release of InsP 3 caused 3-fold greater Ca 2+ release than in nontransgenic neurons and enhanced the number of neurons responding and those exhibiting strong responses (Stutzmann et al., 2004) . By demonstrating that mutant PS sensitizes the InsP 3 R to InsP 3 , our new results provide a molecular mechanism that is consistent with these previous observations and can therefore possibly account for them. To test this idea, the relevance of the observed effects of FAD PS1 expression on InsP 3 R single-channel gating was determined by measuring [Ca 2+ ] i responses in PS-expressing DT40 cells, the same cells used for the single-channel studies, that had comparable levels of InsP 3 R expression. Exaggerated Ca 2+ release responses to both high-as well as low-threshold concentrations of agonist were observed in the cells that expressed the PS1-M146L protein. In a significant proportion of the FAD mutant PS-expressing cells, the [Ca 2+ ] i responses to low agonist concentrations mimicked the responses of normal cells to a saturating agonist concentration. Furthermore, a high percentage of PS1-M146L-expressing unstimulated cells displayed spontaneous low-level [Ca 2+ ] i signals in the absence of agonist stimulation. Most importantly, the exaggerated Ca 2+ responses were mediated specifically by the InsP 3 R, since they were absent in Mattson and Chan, 2003; Stutzmann, 2005) . Although this ''Ca 2+ overload'' hypothesis has been widely invoked, many studies, including ours here, have observed either no alteration or reduced ER Ca 2+ stores in FAD PS-expressing cells (Giacomello et al., 2005; Lessard et al., 2005; Zatti et al., 2004 Zatti et al., , 2006 ] i signaling and ER Ca 2+ content are InsP 3 R dependent, with mutant PS1-and PS2-stimulated InsP 3 R channels remaining regulated by InsP 3 . Thus, cell typespecific differences in concentrations of InsP 3 R ligands and expression levels can contribute to the magnitude of the effect of mutant PS1 expression on ER Ca 2+ , which might reconcile discrepant published observations. The enhanced Ca 2+ release responses observed in PS1-M146L-expressing DT40 cells are highly reminiscent of those in peripheral and neuronal mutant PS-expressing cells in many previous studies. The absence of these responses in InsP 3 R-knockout cells, together with the identification of a molecular mechanism observed at the single channel level, strongly suggest that mutant PS-mediated enhancement of InsP 3 sensitivity of the InsP 3 R is a fundamental underlying mechanism that accounts for many observations of dysregulated Ca 2+ signaling in AD cells and model cell systems.
It has been reported that exaggerated Ca 2+ responses in cells expressing FAD mutant PS are associated with enhanced expression or activities of ryanodine receptor (RyR) Ca 2+ release channels (Chan et al., 2000; Smith et al., 2005b; Stutzmann et al., 2006) . In AD-transgenic mouse cortical neurons, exaggerated responses to InsP 3 were mediated in part by RyR activated by Ca 2+ released through InsP 3 R (Stutzmann et al., 2006) , suggesting that exaggerated RyR responses could be a secondary effect. Because Ca 2+ signaling can influence InsP 3 R (Cai et al., 2004; Genazzani et al., 1999) and RyR (P. Nicotera, personal communication) expression, it is possible that mutant PSmediated enhanced InsP 3 R Ca 2+ signaling drives transcriptional programs, with RyR expression upregulated as a result. Conversely, Ab exposure increased RyR expression in mouse cortical neurons (Supnet et al., 2006) , suggesting that changes in RyR expression may be more downstream compared with a more proximal InsP 3 R-mediated process described here. Alternately, PS and RyR may functionally interact similar to the PS-InsP 3 R interaction. PS2 has been reported to interact with RyR2, the cardiac isoform, and PS2 knockout results in cardiac Ca 2+ signaling abnormalities (Takeda et al., 2005) . In addition,
WT and mutant PS1 have been reported to interact with RyR3 (Chan et al., 2000) . It was proposed that reconstituted PS proteins form divalent cation-permeable ion channels in bilayer membranes and that loss of this function in FAD PS enhanced ER Ca 2+ , resulting in exaggerated Ca 2+ release responses (Nelson et al., 2007; Tu et al., 2006) . In contrast, we did not detect in native ER membranes a cation permeability associated with either WT or FAD mutant PS expression. Furthermore, we found that FAD mutant PS expression either reduced (DT40 cells) or had no effect (cortical neurons) on the amount of Ca 2+ in the ER. Thus, our experiments failed to discover evidence in support of the hypothesis that PS form ion channels. Finally, it should be emphasized that the Ca 2+ signaling abnormalities we observed represent proximal mechanisms distinct from effects of Ab on Ca 2+ signaling (Mattson and Guo, 1997) . Our studies indicate the presence of a complex involving PS and InsP 3 R that results in hyperactivation of the Ca 2+ release channel in a process that is independent of Ab.
Enhanced PS-Dependent InsP 3 R-Mediated Ca
Signaling Enhances Ab Processing Disrupted Ca 2+ signaling in AD cells has been well documented, but its physiological implications and the roles that these changes play in AD pathogenesis have not been well studied. Altered Ca 2+ signaling could impinge on synaptic plasticity, membrane excitability, oxidative stress, and APP processing. Identification of the InsP 3 R as a molecular mechanism of Ca 2+ disruption associated with FAD PS now suggests specific hypotheses that can be tested to evaluate the relevance of altered Ca 2+ signaling through this pathway on disease-associated processes.
Our data suggest that one function of PS proteins may be to regulate the activity of the InsP 3 R. Is there a relationship between this activity and the activity of PS as secretases? APP processing can be enhanced by elevations of [Ca 2+ ] i (Buxbaum et al., 1994; Jolly-Tornetta et al., 1998; Querfurth and Selkoe, 1994) and diminished by inhibition of ER Ca 2+ release (Buxbaum et al., 1994 (Oh and Turner, 2006) . Thus, the g-secretase activity of PS is likely not involved in this mechanism by which mutant PS regulates InsP 3 R channel gating. The dependence of Ab production on InsP 3 R expression observed here suggests that mutant PS-mediated exaggerated Ca 2+ signaling could be a proximal mechanism in AD. Brain Ab production is driven by neuronal activity (Cirrito et al., 2005; Kamenetz et al., 2003) , suggesting that activity and metabolic patterns may contribute to Ab production and amyloid deposition (Buckner et al., 2005) . As-yet-unspecified activity-or metabolism-dependent mechanisms may cause preferential accumulation of amyloid that, over many years, may participate in AD pathology (Buckner et al., 2005) . Because of a central role of Ca 2+ in regulating both neuronal excitability (Verkhratsky, 2005) and cell metabolism (Balaban, 2002; McCormack et al., 1990) These data provide molecular insights into the mechanisms of enhanced InsP 3 -mediated Ca 2+ signals observed in cells that express FAD mutant presenilins, including those from AD patients. Enhanced Ca 2+ release from the ER as a result of this interaction has physiological implications that may be relevant in AD, including enhanced APP processing. These observations may provide unique molecular insights into the ''Ca 2+ dysregulation hypothesis'' of AD pathogenesis and suggest novel targets for therapeutic intervention.
EXPERIMENTAL PROCEDURES
Recombinant Baculovirus Constructs and Sf9 Cell Infection Spodoptera frugiperda cells (Sf9, BD Biosciences) were maintained as described (Ionescu et al., 2006) . Human PS baculovirus constructs (PS1-WT, PS1-M146L, PS2-WT, and PS2-N141I) were subcloned into pFastBac1; baculoviruses were generated using the Bac-to-Bac system (Invitrogen). Expression was confirmed by western blotting with anti-PS1 (monoclonal MAB5232, polyclonal MAB1563, Chemicon International, Inc.) and -PS2 (EMD Chemicals Inc.) antibodies. Localization of PS in Sf9 cells was confirmed by immunocytochemistry with anti-PS1 or -PS2 antibodies. Sf9 nuclei were counterstained with TOTO-3 nuclear dye (Molecular Probes).
Cell Culture and Transfection DT40 cells were maintained as described (White et al., 2005) . Human wild-type (WT) PS1 and M146L cDNAs were subcloned into pIRES2-EGFP (Clontech). Cells were transfected using a Nucleofector Device (Amaxa). To select stable polyclonal lines, transfected cells were cultured for 2 weeks in 2 mg ml À1 Geneticin (Invitrogen). PS expression was confirmed by western blot. Human APP harboring Swedish mutations (APP SWE ) was introduced into PS1-expressing DT 40 lines by retrovirus infection. APP SWE cDNA was subcloned into pDMX-IRES-dsRED retrovirus vector. APP SWE retrovirus was generated using Retro-X system (Clontech). Expression of APP SWE was confirmed by western blotting using a polyclonal anti-APP antibody. Primary cortical neurons were prepared from embryonic day 15 (E15-16) C57BL/6J mice, as described (Meberg and Miller, 2003) . Transfections were performed on 7-to 14-day-old cultures with pIRES2-EGFP-PS1WT, pIRES2-EGFP-M146L, or pIRES2-EGFP empty vector by n-Fect reagent (Neuromics). Experiments performed 48 hr after transfection.
Electrophysiology
Preparation of isolated nuclei from Sf9 or DT40 cells was as described (White et al., 2005) . Nuclei were studied in standard bath solution: 140 mM KCl, 10 mM HEPES, and 0.5 mM BAPTA (free [Ca 2+ ] = 300 nM) (pH 7.3). The pipette solution contained 140 mM KCl, 0.5 mM ATP, 10 mM HEPES, 1 mM free Ca 2+ (pH 7.3). Free [Ca 2+ ] in all solutions was adjusted, as described (Mak et al., 1998) . Data were acquired at room temperature and analyzed as described (Ionescu et al., 2006) .
Single-Cell Ca 2+ Imaging
[Ca 2+ ] i was measured in Fura-2-loaded DT40 cells as described (White et al., 2005) . ER Ca 2+ content was estimated from changes in [Ca 2+ ] i in response to thapsigargin or ionomycin, as described (White et al., 2005) , or with the low-affinity Ca 2+ indicator Mag-Fura-2 (Invitrogen) following procedures similar to those described in Laude et al. (2005) modified for single-cell imaging. Following loading of cells on coverslips with Mag-Fura-2 (10 mM for 60 min), the plasma membranes were permeabilized by exposure to 10 mg/ml digitonin for 2 min in a medium that contained 220 nM Ca 2+ and lacked MgATP. Following 30 min of continuous perfusion with the MgATP-free bath to wash out the digitonin, cells were alternately illuminated with 340/380 nm light and fluorescence intensity at 510 nm was collected with a Perkin Elmer Ultraview imaging system. Changes in [Ca 2+ ] ER are presented as changes in fluorescence ratio (R/R 0 ). R 0 was verified to reflect the ratio for Ca 2+ depleted stores by using ionomycin (1 mM), as described (Laude et al., 2005) . Ca 2+ leak rates expressed as
Amyloid Beta (Ab 40 and Ab 42 ) Determinations Ab levels in culture media were measured by sandwich ELISA (Suzuki et al., 1994) . Briefly, plates were coated with Ab N-terminal antibody Ban50 prior to application of cell media. The concentration of Ab was determined using horseradish peroxidase (HRP)-conjugated BA27 or BC05 antibodies to detect Ab 40 or Ab 42 , respectively. Ab 40 or Ab 42 levels were normalized to total protein concentration. Standard curves, constructed from serial dilutions of synthetic Ab 40 or Ab 42 , were generated in each experiment.
Analysis and Statistics
Data were summarized as the mean ± SEM, and statistical significance of differences between means was assessed using unpaired t tests or analysis of variance (ANOVA) for repeated-measures at the 95% level (p < 0.05).
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www. neuron.org/cgi/content/full/58/6/871/DC1/.
